Saturday, October 31, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 10, 2026

Butterfield (NTB) Q4 2025 Earnings Call Transcript

View original at finance.yahoo.com
Butterfield (NTB) Q4 2025 Earnings Call Transcript Image source: The Motley Fool. DATE Tuesday, Feb. 10, 2026 at 10 a.m…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trust businesses organically grow like 2% a year with natural attrition of about 2%, so growth generally comes through acquisitions

    80% confidence
  • Butterfield is top 5 private trust company in Singapore with great growth opportunities

    80% confidence
  • Trust performance particularly strong due to Credit Suisse asset acquisition now completely integrated and fee standstill expired

    80% confidence
  • FX has been a real source of strength in Q4 and throughout 2025, with new functionality allowing clients to access credit lines for FX

    80% confidence
  • Deposit outflows of $360 million in Q4 were offset by foreign exchange translation gains of $310 million

    80% confidence
  • Noninterest deposit growth in Caymans due to seasonal influx associated with reinsurance payments

    80% confidence
  • Asset management fee strength driven by underlying valuations improving significantly in Q4 and throughout 2025

    80% confidence
  • Some costs in Q4 were one-time and will not repeat, expenses should settle between $90 million and $92 million quarterly

    80% confidence
  • Combined payout ratio of 97% in 2025 from dividend increases and share repurchases

    80% confidence
  • Continue to expect OCI improvement with additional burn down over the next 12 months of 28%

    80% confidence
  • Focused on trust acquisitions in existing jurisdictions: Guernsey, Bermuda, Cayman, Switzerland and Singapore as they are the best trust jurisdictions

    80% confidence
  • Not seeing systemic shifts in NPA migration, movements related to a few commercial accounts scattered throughout the network, mostly in Bermuda

    80% confidence
  • M&A growth strategy remains on track with active dialogue with potential targets

    80% confidence
  • Expect quarterly core expenses to be around $92 million over the next few quarters

    80% confidence
  • In 2025, Butterfield delivered strong financial results through disciplined execution with core net income per share growing 17.4% year-on-year to total $5.60 per share

    80% confidence
  • In 2025, Butterfield continued to produce top quartile returns relative to peers

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com